Tianlong Fu

Zhengzhou Central Hospital

Papers

1

Total Citations

14

H-Index

1

About

Tianlong Fu is a surgical oncologist whose research focuses on improving outcomes for bladder cancer patients undergoing radical cystectomy. His most cited work, a 2019 study with 14 citations, identifies preoperative predictors of early death risk in patients treated with robot-assisted radical cystectomy. This research is critical for risk stratification, as it leverages routine laboratory findings at diagnosis to pinpoint patients at higher risk of mortality within one year of surgery. By highlighting these biomarkers, Fu’s work enables clinicians to tailor perioperative management and potentially improve survival rates. His contributions underscore the importance of integrating simple, accessible data into prognostic models, offering a practical tool for enhancing decision-making in high-risk bladder cancer care. Fu’s research bridges surgical oncology and predictive analytics, providing actionable insights that can directly impact patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative predictors of early death risk in bladder cancer patients treated with robot‐assisted radical cystectomy
14 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Zhengzhou Central Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago